{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:19:52Z","timestamp":1782998392312,"version":"3.54.5"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T00:00:00Z","timestamp":1496707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013116","name":"Merz Pharma","doi-asserted-by":"crossref","award":["#R.14.022"],"award-info":[{"award-number":["#R.14.022"]}],"id":[{"id":"10.13039\/501100013116","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","award":["IT03924"],"award-info":[{"award-number":["IT03924"]}],"id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0178670","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T17:36:40Z","timestamp":1496770600000},"page":"e0178670","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":59,"title":["Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections"],"prefix":"10.1371","volume":"12","author":[{"given":"Olivia","family":"Samotus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandar","family":"Jog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,6,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1517\/14656566.6.3.419","article-title":"Pharmacological treatment of disabling tremor","volume":"6","author":"CR Schadt","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"ref2","first-page":"CD003735","article-title":"Anticholinergics for symptomatic management of Parkinson&apos;s disease","author":"R Katzenschlager","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4137\/JCNSD.S13570","article-title":"Medical treatment of essential tremor","volume":"6","author":"AH Rajput","year":"2014","journal-title":"J Cent Nerv Syst Dis"},{"issue":"9","key":"ref4","first-page":"1266","article-title":"Subthalamic nucleus stimulation: improvements in outcome with reprogramming","volume":"63","author":"E Moro","year":"2006","journal-title":"Arch Neurol"},{"key":"ref5","article-title":"Deep brain stimulation programming: principles and practice","author":"EB Montgomery","year":"2010"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1017\/S0317167100003413","article-title":"Thalamic deep brain stimulation for essential tremor: recommendations for long-term outcome analysis","volume":"31","author":"JD Putzke","year":"2004","journal-title":"Can J Neurol Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2377-14-120","article-title":"Long-term follow-up of thalamic deep brain stimulation for essential tremor\u2014patient satisfaction and mortality","volume":"14","author":"MN B\u00f8rretzen","year":"2014","journal-title":"BMC Neurol"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000163769.28552.CD","article-title":"Practice parameter: Therapies for essential tremor\u2014Report of the quality standards subcommittee of the American academy of neurology","volume":"64","author":"TA Zesiewicz","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/mds.25739","article-title":"Treatment of proximal upper limb tremor with botulinum toxin therapy","volume":"29","author":"SD Kim","year":"2014","journal-title":"Mov Disord"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/mds.870090604","article-title":"Botulinum toxin A injections for the treatment of hand tremors","volume":"9","author":"RM Trosch","year":"1994","journal-title":"Mov Disord"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archneur.1996.00550070055012","article-title":"Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients","volume":"53","author":"SL Pullman","year":"1996","journal-title":"Arch Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor","volume":"11","author":"J Jankovic","year":"1996","journal-title":"Mov Disord"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.parkreldis.2012.04.019","article-title":"Amplitude fluctuations in essential tremor","volume":"18","author":"G Mostile","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"e0153739","DOI":"10.1371\/journal.pone.0153739","article-title":"Functional Ability Improved in Essential Tremor by IncobotulinumtoxinA Injections Using Kinematically Determined Biomechanical Patterns\u2014A New Future","volume":"11","author":"O Samotus","year":"2016","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5334\/tohm.240","article-title":"Effective Management of Upper Limb Parkinsonian Tremor by IncobotulinumtoxinA Injections Using Sensor-based Biomechanical Patterns","volume":"5","author":"F. Rahimi","year":"2015","journal-title":"Tremor Other Hyperkinet Mov (N.Y.)"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1017\/S031716710001489X","article-title":"Effectiveness of BoNT A in Parkinson\u2019s Disease Upper Limb Tremor Management","volume":"40","author":"F Rahimi","year":"2013","journal-title":"Can J of Neurol Sci"},{"key":"ref17","unstructured":"&quot;Product Monograph: IncobotulinumtoxinA.&quot; Xeomin Product Monograph. Merz Pharmaceuticals, June 2013. Web."},{"key":"ref18","first-page":"271","article-title":"Parkinson\u2019s Disease and Movement Disorders","author":"S Fahn","year":"1993"},{"issue":"15","key":"ref19","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson&apos;s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results","volume":"23","author":"CG Goetz","year":"2008","journal-title":"Mov Disord"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.parkreldis.2005.05.009","article-title":"Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validation","volume":"11","author":"AI Tr\u00f6ster","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1197\/j.jht.2005.02.009","article-title":"Measurement of Health Outcomes Following Tendon and Nerve Repair","volume":"18","author":"F MacDermid","year":"2005","journal-title":"J Hand Ther"},{"key":"ref22","article-title":"Handbook of Manual Muscle Testing","author":"NC Cutter","year":"1999"},{"key":"ref23","unstructured":"Bates D, Maechler M, Bolker B, Walker S. lme4: Linear Mixed-effects Models Using Eigen and S4. R package version 1.1\u20130. 2013. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/cran.r-project.org\/package=lme4\" xlink:type=\"simple\">https:\/\/cran.r-project.org\/package=lme4<\/ext-link>."},{"key":"ref24","unstructured":"Lenth RV. Using lsmeans. R package version 2.25\u20135. 2017. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/cran.r-project.org\/package=lsmeans\" xlink:type=\"simple\">https:\/\/cran.r-project.org\/package=lsmeans<\/ext-link>."},{"issue":"0","key":"ref25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.toxicon.2014.07.009","article-title":"Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up","volume":"90","author":"J Ramirez-Castaneda","year":"2014","journal-title":"Toxicon"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/toxins5020249","article-title":"Long-term efficacy and safety of botulinum toxin injections in dystonia","volume":"5","author":"J Ramirez-Castaneda","year":"2013","journal-title":"Toxins (Basel)"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/mds.26383","article-title":"Therapeutic advances in tremor","volume":"30","author":"A Fasano","year":"2015","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"ref28","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S1353-8020(11)70030-X","article-title":"Tremor revisited: treatment of PD tremor","volume":"18","author":"MC Jim\u00e9nez","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00702-015-1439-8","article-title":"Wearable sensor-based objective assessment of motor symptoms in Parkinson\u2019s disease","volume":"123","author":"C Ossig","year":"2016","journal-title":"J Neural Transm (Vienna)"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1017\/cjn.2015.12","article-title":"Dynamic decomposition of motion in essential and parkinonian tremor","volume":"42","author":"F Rahimi","year":"2015","journal-title":"Can J Neurol Sci"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.56.11.1523","article-title":"A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor","volume":"56","author":"MF Brin","year":"2001","journal-title":"Neurology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.toxicon.2012.12.004","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders","volume":"67","author":"M Hallett","year":"2013","journal-title":"Toxicon"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0178670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T15:38:35Z","timestamp":1602257915000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0178670"}},"subtitle":[],"editor":[{"given":"Alfonso","family":"Fasano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,6]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0178670","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,6]]}}}